Neurologic Complications of Bone Marrow, Stem Cell, and Organ Transplantation in Patients With Cancer

Seminars in Oncology

Volumn 33, Issue 3, 2006, Pages 352-361

  Rosenfeld, Myrna R ^a   Pruitt, Amy ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ARABINOSIDE; AZATHIOPRINE; BUSULFAN; CARBOPLATIN; CARMUSTINE; CEFEPIME; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DIAZEPAM; ETOPOSIDE; GANCICLOVIR; GEMCITABINE; IFOSFAMIDE; IMIPENEM; METHOTREXATE; METHYLENE BLUE; OKT 3; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY; UNINDEXED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; APHERESIS; ARTICLE; AUDITORY HALLUCINATION; AUTOIMMUNE DISEASE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; BRADYCARDIA; BRAIN DISEASE; BRAIN INFARCTION; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBELLUM DISEASE; CEREBROVASCULAR DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COGNITIVE DEFECT; COMA; CONFUSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEART ARRHYTHMIA; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOMAGNESEMIA; HYPOTENSION; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION PREVENTION; INFECTION RISK; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LETHARGY; LEUKOENCEPHALOPATHY; LIVER FAILURE; LIVER TRANSPLANTATION; LYMPHOMA; METABOLIC DISORDER; MULTIPLE SCLEROSIS; MUSCLE RIGIDITY; MYCOSIS; MYELOABLATIVE CONDITIONING; MYELORADICULOPATHY; MYOCLONUS; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; OPTIC DISK; ORGAN TRANSPLANTATION; OTOTOXICITY; PAIN; PARKINSONISM; PATIENT CARE; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RADIATION INJURY; REDUCED INTENSITY CONDITIONING; RETINA DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SEIZURE; SOMNOLENCE; STEM CELL TRANSPLANTATION; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LEUKEMIA; TRANSIENT GLOBAL AMNESIA; TREMOR; VIRUS INFECTION; VISUAL HALLUCINATION; VISUAL IMPAIRMENT; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES; ORGAN TRANSPLANTATION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TISSUE AND ORGAN HARVESTING; TRANSPLANTATION CONDITIONING; TRANSPLANTS;

EID: 33744916747     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.03.003     Document Type: Article

References (72)

1. Bleggi-Torres L.F., de Medeiros B.C., Werner B., et al. Neuropathological findings after bone marrow transplantation. An autopsy study of 180 cases. Bone Marrow Transplant 25 (2000) 301-307
2. Mohrmann R.L., Mah V., and Vinters H.V. Neuropathologic findings after bone marrow transplantation. An autopsy study. Hum Pathol 21 (1990) 630-639
3. Snider S., Bashir R., and Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 44 (1994) 681-684
4. Guerrero A., Perez-Simon J.A., Gutierrez N., et al. Neurological complications after autologous stem cell transplantation. Eur Neurol 41 (1999) 48-50
5. de Brabander C., Cornelissen J., Smitt P.A., et al. Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 68 (2000) 36-40
6. Saiz A., and Graus F. Neurological complications of hematopoietic cell transplantation. Semin Neurol 24 (2004) 427-434
7. Sostak P., Padovan C.S., Yousry T.A., et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60 (2003) 842-848
8. Faraci M., Lanino E., Dini G., et al. Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 59 (2002) 1895-1904
9. Uckan D., Cetin M., Yigitkanli I., et al. Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 35 (2005) 71-76
10. Antonini G., Ceschin V., Morino S., et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia. A prospective study. Neurology 50 (1998) 1441-1445
11. Bain B.J. Bone marrow biopsy morbidity. Review of 2003. J Clin Pathol 58 (2005) 406-408
12. Lieberman F., and Gulati S. Headaches after inadvertent lumbar puncture during bone marrow harvest. Neurology 46 (1996) 268-269
13. Burt R.K., Fassas A., Snowden J., et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 28 (2001) 1-12
14. Openshaw H., Stuve O., Antel J.P., et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 54 (2000) 2147-2150
15. Reddy V., Hill G.R., Pan L., et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 69 (2000) 691-693
16. Hartung T., Doecke W.D., Bundschuh D., et al. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther 66 (1999) 415-424
17. Kassim A.A., Chinratanalab W., Ferrara J.L., et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias. 'What is the best recipe?'. Bone Marrow Transplant 36 (2005) 566-574
18. Sylvestre D.L., Sandson T.A., and Nachmanoff D.B. Transient brachial plexopathy as a complication of internal jugular vein cannulation. Neurology 41 (1991) 760
19. Heckmann J.G., Lang C.J., Kindler K., et al. Neurologic manifestations of cerebral air embolism as a complication of central venous catheterization. Crit Care Med 28 (2000) 1621-1625
20. Hoyt R., Szer J., and Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 25 (2000) 1285-1287
21. Higman M.A., Port J.D., Beauchamp Jr. N.J., et al. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 26 (2000) 797-800
22. Ferrucci P.F., Martinoni A., Cocorocchio E., et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 25 (2000) 173-177
23. Krouwer H.G., and Wijdicks E.F. Neurologic complications of bone marrow transplantation. Neurol Clin 21 (2003) 319-352
24. Cree B.C., Bernardini G.L., Hays A.P., et al. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 60 (2003) 107-112
25. Batchelor T.T., Taylor L.P., Thaler H.T., et al. Steroid myopathy in cancer patients. Neurology 48 (1997) 1234-1238
26. Freise C.E., Rowley H., Lake J., et al. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc 23 (1991) 3173-3174
27. Reece D.E., Frei-Lahr D.A., Shepherd J.D., et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 8 (1991) 393-401
28. Walker R.W., and Brochstein J.A. Neurologic complications of immunosuppressive agents. Neurol Clin 6 (1988) 261-278
29. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
30. Kochi S., Takanaga H., Matsuo H., et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci 66 (2000) 2255-2260
31. Pranzatelli M.R., Mott S.H., Pavlakis S.G., et al. Clinical spectrum of secondary parkinsonism in childhood. A reversible disorder. Pediatr Neurol 10 (1994) 131-140
32. Balmaceda C.M., Walker R.W., Castro-Malaspina H., et al. Reversal of amphotericin-B-related encephalopathy. Neurology 44 (1994) 1183-1184
33. Spitzer T.R. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27 (2001) 893-898
34. Oyama Y., Cohen B., Traynor A., et al. Engraftment syndrome. A common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 29 (2002) 81-85
35. Wainwright M.S., Martin P.L., Morse R.P., et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50 (2001) 612-619
36. Tsujimura H., Iseki T., Date Y., et al. Human herpesvirus-6 encephalitis after bone marrow transplantation. Magnetic resonance imaging could identify the involved sites of encephalitis. Eur J Haematol 61 (1998) 284-285
37. Pickhardt P.J., and Siegel M.J. Posttransplantation lymphoproliferative disorder of the abdomen. CT evaluation in 51 patients. Radiology 213 (1999) 73-78
38. Miller Jr. W.T., Siegel S.G., and Montone K.T. Posttransplantation lymphoproliferative disorder. changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging 38 (1997) 569-585
39. Castellano-Sanchez A.A., Li S., Qian J., et al. Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121 (2004) 246-253
40. Parker P., Chao N.J., Ben Ezra J., et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore) 75 (1996) 279-285
41. Grau J.M., Casademont J., Monforte R., et al. Myasthenia gravis after allogeneic bone marrow transplantation. Report of a new case and pathogenetic considerations. Bone Marrow Transplant 5 (1990) 435-437
42. Adams C., August C.S., Maguire H., et al. Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 12 (1995) 58-61
43. Tse S., Saunders E.F., Silverman E., et al. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease. Bone Marrow Transplant 23 (1999) 397-399
44. Solaro C., Murialdo A., Giunti D., et al. Central and peripheral nervous system complications following allogeneic bone marrow transplantation. Eur J Neurol 8 (2001) 77-80
45. Zivkovic S., Abu Elmagd K.M., and Bond G. Long-term neurologic complications associated with intestinal and multivisceral transplantation. Neurology 64 suppl 1 (2005) A123 (abstr)
46. Srinivasan A., Burton E.C., Kuehnert M.J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 352 (2005) 1103-1111
47. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348 (2003) 2196-2203
48. Opelz G., and Dohler B. Lymphomas after solid organ transplantation. A collaborative transplant study report. Am J Transplant 4 (2004) 222-230
49. Gottschalk S., Rooney C.M., and Heslop H.E. Post-transplant lymphoproliferative disorders. Annu Rev Med 56 (2005) 29-44
50. Paraskevas S., Coad J.E., Gruessner A., et al. Posttransplant lymphoproliferative disorder in pancreas transplantation. A single-center experience. Transplantation 80 (2005) 613-622
51. Dharnidharka V.R., Sullivan E.K., Stablein D.M., et al. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71 (2001) 1065-1068
52. Swinnen L.J., Costanzo-Nordin M.R., Fisher S.G., et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323 (1990) 1723-1728
53. Newell K.A., Alonso E.M., Whitington P.F., et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 62 (1996) 370-375
54. Safdar A., Papadopoulous E.B., and Armstrong D. Listeriosis in recipients of allogeneic blood and marrow transplantation. Thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection. Bone Marrow Transplant 29 (2002) 913-916
55. Robak T. Alemtuzumab in the treatment of chronic lymphocytic leukemia. BioDrugs 19 (2005) 9-22
56. Buckanovich R.J., Liu G., Stricker C., et al. Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Ann Hematol 81 (2002) 410-413
57. Lewis M.B., and Howdle P.D. Neurologic complications of liver transplantation in adults. Neurology 61 (2003) 1174-1178
58. Boon AP, Carey MP, Adams DH, et al: Central pontine myelinolysis in liver transplantation. J Clin Pathol 44:909-914, 199.
59. Lindzen E., Gilani A., Markovic-Plese S., et al. Acute disseminated encephalomyelitis after liver transplantation. Arch Neurol 62 (2005) 650-652
60. Deutsch E.S., Bartling V., Lawenda B., et al. Sensorineural hearing loss in children after liver transplantation. Arch Otolaryngol Head Neck Surg 124 (1998) 529-533
61. Glass G.A., Stankiewicz J., Mithoefer A., et al. Levetiracetam for seizures after liver transplantation. Neurology 64 (2005) 1084-1085
62. Hollenbeak C.S., Todd M.M., Billingsley E.M., et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 104 (2005) 1962-1967
63. De La Camara R., Tomas J.F., Figuera A., et al. High dose busulfan and seizures. Bone Marrow Transplant 7 (1991) 363-364
64. Vassal G., Deroussent A., Hartmann O., et al. Dose-dependent neurotoxicity of high-dose busulfan in children. A clinical and pharmacological study. Cancer Res 50 (1990) 6203-6207
65. Parsons S.K., Neault M.W., Lehmann L.E., et al. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 22 (1998) 669-674
66. Johnson D.W., Cagnoni P.J., Schossau T.M., et al. Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support. Bone Marrow Transplant 24 (1999) 785-792
67. Burger P.C., Kamenar E., Schold S.C., et al. Encephalomyelopathy following high-dose BCNU therapy. Cancer 48 (1981) 1318-1327
68. Baker W.J., Royer Jr. G.L., and Weiss R.B. Cytarabine and neurologic toxicity. J Clin Oncol 9 (1991) 679-693
69. Leff R.S., Thompson J.M., Daly M.B., et al. Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer 62 (1988) 32-35
70. Pratt C.B., Goren M.P., Meyer W.H., et al. Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors. J Clin Oncol 8 (1990) 1399-1401
71. DiMaggio J.R., Brown R., Baile W.F., et al. Hallucinations and ifosfamide-induced neurotoxicity. Cancer 73 (1994) 1509-1514
72. Pelgrims J., De Vos F., Van den B.J., et al. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy. Report of 12 cases and a review of the literature. Br J Cancer 82 (2000) 291-294